Metoclopramide for Hiccups
For persistent hiccups, metoclopramide 10 mg orally three times daily is a reasonable treatment option, though evidence is limited and other agents may be more effective.
Dosing Regimen
The evidence supports the following approach:
- Standard dose: 10 mg orally three times daily for up to 15 days 1
- Alternative dosing: 5-20 mg orally or IV as needed 2, 3, 4
- Intramuscular option: 10 mg IM twice daily has been used in stroke patients 5, 6
The FDA label does not specifically list hiccups as an approved indication, though metoclopramide is used off-label for this purpose 7.
Evidence Quality and Efficacy
The evidence for metoclopramide in hiccups is weak. A 2014 randomized controlled trial (the only RCT available) showed that 10 mg three times daily for 15 days had higher total efficacy than placebo (relative risk 2.75,95% CI: 1.09-6.94, p=0.03) 1. However, this was a small pilot study with only 34 completers.
Important limitation: Recent comparative studies suggest metoclopramide may be inferior to other treatments. Two 2025 studies in post-stroke patients found peripheral magnetic stimulation achieved 100% clinical efficacy versus only 55.6% for metoclopramide injections 5, 6. A systematic review found metoclopramide had only 55.3% efficacy as first-line treatment 8, 9.
Critical Precautions
You must discuss these risks before prescribing:
- Tardive dyskinesia risk: FDA black box warning exists 10. While absolute risk is low, this potentially irreversible movement disorder is the primary safety concern
- Higher risk populations: Elderly patients and those on psychotropic agents face increased adverse event risk 10
- Common adverse effects: Restlessness, drowsiness, diarrhea, muscle weakness, dystonic reactions 2
- Contraindications: Pheochromocytoma, seizure disorder, GI bleeding, GI obstruction 2
Monitoring Requirements
- Assess efficacy and adverse effects (including movement disorders) at 4-8 weeks 10
- Continue monitoring for the entire duration of therapy
- Consider drug holidays (1-4 weeks off every 8-12 weeks) to improve tolerability 10
Alternative Agents to Consider
Based on the evidence, chlorpromazine remains the only FDA-approved agent for hiccups and may be more effective 8, 11. Other options with evidence include:
- Baclofen: Studied in RCTs with good efficacy (76.1% response rate) 8, 9
- Gabapentin: Prospective evidence available 8, 12
- Chlorpromazine: 10-25 mg oral/IM with complete resolution in multiple studies 11, though carries risk of hypotension and extrapyramidal symptoms
Clinical Algorithm
- Start with metoclopramide 10 mg PO TID if patient has no contraindications and accepts tardive dyskinesia risk
- Assess response after 3-7 days
- If inadequate response (>50% of patients): Switch to baclofen or chlorpromazine rather than continuing ineffective therapy
- If response but intolerable side effects: Consider gabapentin or pregabalin as alternatives 12
- Renal impairment: Reduce dose by 50% if creatinine clearance <40 mL/min 7
Key Pitfall
Do not persist with metoclopramide monotherapy if hiccups continue after one week—the evidence shows limited efficacy and you're exposing patients to tardive dyskinesia risk without benefit. The 55% efficacy rate means nearly half of patients will need alternative therapy 9.